MTOR and cancer: LY3023414, the PI3K/mTOR/DNA‐PK inhibitor, pleotropic modulator CC‐122 and CC‐115, the mTOR/DNA‐PK inhibitor, not only target DNA‐PKcs, but also suppress cancer relevance kinases.